Filing Flows

Filing Flows › Iradimed (IRMD) › Next earnings date

Iradimed (IRMD) earnings: matched the estimate

Iradimed (IRMD) reported on Oct 30, 2026 and matched the EPS estimate: $0.55 against $0.55 (+0.0%). Revenue was $24.2M for Q3 2026, +14% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+0.0% vs estimate
Beat rate80%

The last report

Iradimed reported revenue of $24.2M for the third quarter 2026 (+14% Y/Y), net earnings $6.5M: Total devices revenue $17.2M, Disposables $5.0M, Services and other $1.2M, Amortized Revenue $801K. How it makes money → · Every quarter →

Iradimed: EPS against the estimate, last 5 reportsIradimed: EPS against the estimate, last 5 reportsEstimateReported$0.46$0.47Nov 25$0.48$0.54Feb 26$0.45$0.49May 26$0.44$0.46Jul 26$0.55$0.55Oct 26
Latest (Oct 26): Estimate $0.55, Reported $0.55.
IRMD: the stock's move on each reportIRMD: the stock's move on each reportJul 31, 2026-3.8%May 1, 2026+1.8%Feb 10, 2026+7.4%Nov 3, 2025+12.9%

Iradimed's latest quarter

Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did Iradimed beat earnings?

Iradimed (IRMD) reported on Oct 30, 2026 and matched the EPS estimate: $0.55 against $0.55 (+0.0%).

When does IRMD report earnings?

The next date is not set yet.

Does Iradimed usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.